• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Monday, August 24, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

University of Birmingham becomes partner in €19 million European heart disease project

Bioengineer by Bioengineer
July 19, 2017
in Health
Reading Time: 1 min read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

(University of Birmingham) The University of Birmingham is part of a major new €19 million project aimed at breaking new ground for the development of treatments for millions of patients with heart disease in Europe.

Share12Tweet8Share2ShareShareShare2

Related Posts

Study reveals surge in type 2 diabetes among people under 20

August 24, 2026

Blocking glucosylceramide production kills cancer cells via lysosomal dysfunction, not ceramide buildup

August 23, 2026

ZCCHC4 boosts replication-dependent histone mRNA translation by interacting with eIF3

August 23, 2026

Tirzepatide Versus GLP-1 Agonists for Stroke Risk in Atrial Fibrillation and Diabetes

August 22, 2026
Please login to join discussion

POPULAR NEWS

  • Study reveals surge in type 2 diabetes among people under 20

    29 shares
    Share 12 Tweet 7
  • KAIST discovers pathway to faster-charging, longer-lasting electric vehicle batteries

    29 shares
    Share 12 Tweet 7
  • Blocking glucosylceramide production kills cancer cells via lysosomal dysfunction, not ceramide buildup

    29 shares
    Share 12 Tweet 7
  • ZCCHC4 boosts replication-dependent histone mRNA translation by interacting with eIF3

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Study reveals surge in type 2 diabetes among people under 20

KAIST discovers pathway to faster-charging, longer-lasting electric vehicle batteries

Blocking glucosylceramide production kills cancer cells via lysosomal dysfunction, not ceramide buildup

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 85 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.